Loading…
Please register to continue your trial period!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Acinetobacter baumannii is a health-care-associated opportunistic pathogen with high antimicrobial resistance and was the second leading cause of deaths directly attributable to antimicrobial resistance in 2021 (1, 2, 3)
In 2024, the World Health Organization listed carbapenem-resistant Acinetobacter baumannii as the highest-priority target for antibiotic research and development (4).
Acinetobacter baumannii can colonize any site in the body, and asymptomatic colonization is linked to a higher risk of infection and mortality in hospitalized patients (3, 5, 6, 7, 8, 9, 10).
#…